NCT04013243View on ClinicalTrials.gov

Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
Magnesium Sulfate Causing Adverse Effects in Therapeutic UseNeuromuscular Blockade
Interventions
DRUG

Magnesium Sulfate

magnesium sulphate 50mg/kg in normal saline 50ml infusion for 10minutes for loading dose followed by 15mg/kg/hr for continuous infusion

DRUG

Placebo

Normal Saline 50ml infusion for loading dose followed by continuous infusion for same dose of magnesium.

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT04013243 - Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade | Biotech Hunter | Biotech Hunter